Purchases and Sales Made in Q3 2023 in Aeglea Bio Therapeutics, Inc. (AGLE)
This table provides information about the institutional ownership of Aeglea Bio Therapeutics, Inc. (AGLE) during Q3 2023. The information is specifically focused on institutions that hold shares of Aeglea BioTherapeutics, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Nov 14, 2023
Q3 2023
|
Yu Fan
Hong Kong, K3 |
SELL
|
- |
-91.5K- 81.62% |
$39.3K - $1.37M
|
20.6K
$570K
|
|
|
Nov 14, 2023
Q3 2023
|
Vr Adviser, LLC
New York, NY |
SELL
|
- |
-6.05M- 95.35% |
$2.6M - $90.4M
|
295K
$8.16M
|